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IT is a common clinical observation that patients operated upon for malignant
tumors may later show marked differences with respect to the length of time
before metastases appear. In some patients metastases are discovered within a
few months ofthe removal ofthe primary tumor while in others metastases do not
become apparent until many months, or even years, after the primary tumor has
been removed.
Since clinical knowledge of this phenomenon is scanty and mostly has come
from single case reports, it seemed that a review of the autopsy records ofpatients
who had died of malignant tumors that had metastasized might provide useful
information about the natural history of metastases and suggest possible reasons
for the obvious differences in the length of time required for their development.
Accordingly, the autopsy protocols of all patients with tumors who died in our
Hospital over a 12-year period were analyzed with respect to the interval of time
between the removal of the primary tumor and the first appearance ofmetastases.
Analysis ofthese data suggests that some inherent property ofthe tumor may have
played a part in the development of the metastases that became apparent only
after a long post-operative interval.
MATERIALS AND METHODS
The protocols of 3800 consecutive autopsies performed between February 1946
and October 1958 were examined. Among these a total of 1038 malignant
tumors was found. Metastases were present at autopsy in 759 cases, ofwhich 736
were epithelial tumors and 23 sarcomas (Table I). Cases without metastases at
the time of death were excluded from further study.
For the 759 cases oftumors with metastases, the following data were recorded:
(1) the histologic type of the primary tumor and the age and sex of the patient;
(2) the date of onset of symptoms; (3) the date of surgery, if any; (4) the date
of initial clinical detection of metastases; (5) the date of death; and (6) the
distribution ofmetastases in the various organs at the time of death. The date of
onset of symptoms was taken as the time when signs thought to be related to the
tumor were either first noted by the patient, or were discovered by the physician.
The date of initial appearance of metastases was taken as the time when surgical,
clinical or roentgenological evidence of metastatic disease became evident, or when
a definite change occurred in the patient's well-being that could reasonably be
related to metastases demonstrated at a later date. If metastatic disease wasJ. HENNEFORD, R. BASERGA AND W. B. WARTMAN
discovered only at autopsy, the date of death was recorded as that of initial
appearance of metastases.
From these data, it was possible to calculate the median interval between the
iniitial detection of metastases and death for each kind of tumor. The median,
rather than the mean, was chosen because it is not influenced by inordinately long
or short intervals. The advantages of the median over a mean survival time or a
five-year survival rate have been previously outlined by Schrek (1956).
In 361 of the 759 cases with metastatic dissemination at the time of death,
metastases were not detectable at the time of removal of the primary growth.
These cases were then subdivided into 3 groups:
(1) cases in which metastases became apparent within two years after surgery.
(2) cases in which metastases made their initial appearance or were detected
from two to five years after surgery.
(3) cases in which metastases made their initial appearance five or more years
after surgical intervention.
In the present study, late metastases are defined as metastases appearing after
an arbitrary interval of two or more years following surgical intervention for
removal of the primary growth. Such patients constitute about 10 per cent of
all patients with metastases.
RESULTS
Metastases were present in 73 per cent of all cases of malignant tumors in
our autopsy series (Table I). This incidence of metastases is similar to that
reported by Walther (1948), who found metastases in 68 per cent of 2088 autop-
sies on patients with malignant disease (including primary tumors of the central
nervous system). Table II shows the incidence of late metastases in our series.
In 67 of the 361 cases without metastases at the time of operation, the first meta-
TABLE I. Incidence of Metastases in Various Tumors at the Time of Death
Total Number of Percent of
number cases with cases with
Primary tumor of cases metastases metastases
Sarcomas . . . 24 . 23 . 96
Carcinoma of cervix . 20 . 20 100
Melanoma ofskin . . 11 11 . 100
Carcinoma of gallbladder . 11 . 11 100
Cascinoma of bile ducts . . 9 9 . 100
Carcinoma of pharynx 9 9 100
Carcinoma of thyroid 7 7 100
Melanoma of eye 2 2 100
Carcinoma of ovary . 42 40 95
Carcinoma of breast . 84 79 . 94
Carcinoma of stomach 72 68 . 94
Carcinoma of colon . 154 138 90
Carcinoma of lung . 121 107 88
Carcinoma of endometrium 16 14 87
Carcinoma of pancreas . 48 41 85
Carcinoma of urinary bladder 42 31 74
Carcinoma of liver . 21 . 15 . 71
Carcinoma of kidney . 20 13 . 65
Carcinoma of prostate 67 33 49
Other tumors . 258 88 34
Total . . 1038 . 759 . 73
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TABLE II.-Frequency of Metastases Appearing Two or More Years
After Excision of the Primary Tumor
Metastases appeared Metastases appeared
two or more years after five or more years after
excision ofprimarytumor excisionofprimarytumor
- ' - r -
Primary tumor *N Number Percent Number Percent
Carcinoma of prostate . . 11 . 5 45 5 45
Carcinoma of breast . . . 68 . 23 34 . 7 10
Sarcomas. . . . . 12 . 3 25 . 1 8
Carcinoma of colon . 99 20 20 . 3 3
Carcinoma of urinary bladder . 25 . 3 12 . 2 8
Carcinoma of ovary . . 24 . 2 8 0 0
Carcinoma of endometrium . 12 . 1 8 . 0 0
Carcinoma of stomach 28 . 2 7 0 0
Carcinoma of lung . . 24 . 0 0 0 0
Other tumors . . . 22 . 0 0 0 0
N Less than 10 cases.
Melanoma of eye . . . 2 . 2 100 . 1 50
Carcinoma of thyroid . . 2 . 1 50 . 0 0
Melanoma of skin . . . 5 . 2 40 . 1 20
Carcinoma of pharynx . . 3 . 1 33 . 0 0
Carcinoma of cervix . . . 6 1 16 . 0 0
Carcinoma of kidney . . . 7 . 1 14 . 0 0
Carcinoma of gall bladder . 6 . 0 0 . 0 0
Carcinoma of pancreas 4 . 0 0 . 0 0
Carcinoma of bile duct . 1 . 0 0 . 0 0
Total . . . . 361 . 67 19 . 20 55
* N = Number of cases in which metastases were not detectable at the time the primary tumor
was excised.
stases became clinically detectable two or more years after the removal of the
primary tumor. The primary tumors that most frequently gave rise to late
metastases, as shown by Table II, were: carcinoma ofthe prostate, carcinoma of
of the breast, various sarcomas, carcinoma of the colon, and carcinoma of the
urinary bladder.
Incidence oflate metastases in selected tumors with a similar distribution ofmetastases
According to Walther (1948), the spread of tumors by the blood stream is
governed by established hydrodynamic laws which allow a classification into vari-
ous types depending upon the major venous drainage. Thus, tumors ofthe portal
or caval type are tumors drained, respectively, by the portal or peripheral venous
systems, whereas tumors ofpulmonary vein type are primary in the lungs. These
general types are somewhat modified by peculiarities in the local blood supply
and by the presence or absence of a collateral circulation (Batson, 1942; Lore,
Madden and Gerold, 1958; Coman, 1953), so that occasionally dissimilar types of
tumors may have a comparable distribution ofmetastases. For the present study,
we have selected two pairs of tumors of which both members of each pair have a
similar distribution of metastases in various organs. These are carcinoma of the
breast and lung, and carcinoma of the colon and stomach (Fig. 1). The number,
median age, and sex incidence for these tumors are shown in Table III.
Fig. 2 shows the organ distribution of early and late metastases from primary





tumor Total Men Women age
Breast . . 68 68 58
Lung. . 24 18 6 60-5
Colon . . 99 47 52 . 60
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FIG. 1.-Distribution of metastases in various organs in primary carcinoma of the breast,
lung, colon and stomach.
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Lung Liver Bones Adrenal Brain Kidney Spleen Heart Thyroid
FIG. 2.-An organ-by-organ comparison of early (non-delayed) and late (delayed) metastases
from primary carcinoma of the breast and colon.
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not differ from the general pattern of metastases of the primary tumor, although
late metastases are more frequently multiple and more widely disseminated
than early metastases.
Although the distribution of metastases in the various organs is similar for
each pair of tumors, it can be seen from Table II that 45 per cent of the cases of
carcinoma of the breast had late metastases as compared to none for the lung,
and 20 per cent ofcarcinomas ofthe colon had late metastases against 7 per cent for
carcinoma of the stomach.
Relationship between the incidence of late netastases and death rate
The median intervals between discovery of metastases and death were cal-














FIG. 3. A comparison of two median time intervals in primary carcinoma of the breast, lung,
colon and stomach: the median survival time and the median interval between appearance
of metastases and death.
Fig. 3, where the median survival times for these same tumors are also indicated
for purposes ofcomparison. It should be noted that in all these cases the primary
tumor had been previously removed, and the distribution of metastases in the
various organs at autopsy was similar for each pair of tumors, and in the case of
the stomach-colon pair, the patients are also matched by age and sex.
A comparison of Table I and Fig. 3 shows that the tumors with the longer
interval between onset of metastasis and death have a higher incidence of late
metastases. That one is not the consequence ofthe other is suggested by the fact
that patients with carcinoma of the stomach have a slightly shorter interval be-
tween onset of metastases and death than patients with carcinoma of the lung;
yet they have a higher incidence of delayed metastases.
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DISCUSSION
A number of authors have reported cases in which metastases or recurrence
appeared 10, 20 or even 30 years after the removal of a primary tumor (Hinde-
Nielsen, 1934; Terry and Johns, 1935; Prentice, 1938; Hutcheson, 1952;
Danckers, Hamann and Savage, 1960; Rosof and Rubin, 1960; Morgenstern,
1960; Sutton, 1960). On the basis of such long time intervals between removal
ofthe primary growth and reappearance of the tumor, a theory has been evolved
stating that cancer cells may remain dormant for a long period of time (Hadfield,
1954). This theory has been extrapolated to explain metastases appearing after
a variable time following the removal of the primary growth, the interval being
free of clinical symptoms ofmalignant disease. One may assume that a dormant
cell is a live cell in which there is partial or complete cessation ofmitotic division.
Hadfield has compared dormant cancercellstofrozencellswhich can be kept meta-
bolically inactive at low temperatures for long periods of time and yet promptly
resume division when brought back to normal body temperature. Dormant cells
do not necessarily have to be metabollcally inactive. It is known that ionizing
radiations can inhibit mitosis for long periods of time (Vermund, 1959; Scanlon,
1959), yet, when division resumes the irradiated cells divide again at the same rate
of comparable non-irradiated cells (Baserga, Lisco and Cater, 1961). A similar
situationisrecognizedinhibernatinganimals (LymanandFawcett, 1954). Studies
on bacteria and tissue cultures have shown that cells in which mitosis has been
inhibited under similar circumstances still retain their capability of synthesizing
proteins, ribonucleic acid, etc., and thus are metabolically active, although in-
capable ofdividing (BarnerandCohen, 1956; Kleinand Frossberg, 1954; Rueckert
and Mueller, 1960). It is possible that a similar situation may occur when cancer
cells lodge in distant organs. This possibility is supported by the experimental
findings of Fisher and Fisher (1959) who were able to increase the incidence of
hepatic metastases from Walker carcinoma in rats by simply stressing the animals
at various times after the intravenous portal injection of tumor cells. Presum-
ably some factor or factors related to the stress phenomenon stimulate or
" activate " the growth of tumor cell emboli which otherwise are undetected.
At variance with the above mentioned hypothesis, Collins, Loeffler and Tivey
(1956) have maintained that the main factor concerned with the delayed appear-
ance of metastases is the growth rate of the tumor, and that it is not necessary
to postulate that sleeping tumor cells suddenly begin to grow. These authors
observed that growth rate of human tumors by X-ray films and showed that a
specific rate of growth was characteristic of any individual tumor, and that each
tumor would double its size in a given time. Metastases of a tumor having a
doubling time of 60 days would require approximately five years to grow from a
one-cell stage to a 1 cm. nodule. Similar reasons were used by Brues et al.(1933),
to explain the delay occurring between the administration of a carcinogenic agent
and the appearance of the primary tumor in experimental animals, as well as by
Spratt and Ackerman (1961) to describe the growth of a colonic adenocarcinoma.
Indirect support for the " growth rate " theory was given by the experimental
findings of Baserga, Kisieleski and Halvorsen (1960), who found, in mice, that
injected tumor cells were capable ofsynthesizing DNA in preparation for division
within two hours after lodging in distant organs and that, afterwards, they grew
at a uniform rate for the duration of the experiment.
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The present investigation was undertaken to determine if the pattern of blood-
borne metastases in cancer patients would throw some light on the problem of
late metastases. Retrospective investigations on autopsy material have inherent
limitations, some of which must be briefly discussed at this point. In the first
place, it must be understood that an autopsy population is a biased population
from which patients who have been cured of their cancer have been excluded.
For the purpose ofthe present investigation, however, an autopsy population offers
the considerable advantage of giving a reasonably correct distribution and fre-
quency of metastases in the various organs.
It should also be noted that the definition of late metastases is arbitrary. In
fact, latent metastases, as referred to in the literature, are usually cases in which
metastases make their initial appearance several years after removal oftheprimary
growth, and would correspond to the third group of patients in TableI. Because
we have chosen a two-year symptom-free interval as the arbitrary limit, we have
used the term "late" rather than the more commonly used term of
"latent
metastases ". One could go further and question the whole concept of latent or
late metastases on the grounds that late metastases may simply be the expression
of an early diagnosis of the primary growth. The fact, however, remains that
patients operated upon for malignant tumors do show marked differences with
respect to the length of time before metastases appear and, although the term
"latent " or "late" may be misleading, they have entered into the common use
to indicate differences in the length of the symptom-free intervals between surgery
and appearance of metastases.
In this respect, the present study matches two populations of cancerpatients:
one in which metastases appeared within two years after the removal of the pri-
mary growth against another group in which metastases appeared two or more
years after surgery, and this division is comparable to dividing patients into those
surviving for more or for less than two years after surgery. It is of course very
difficult to match perfectly groups of patients that have different kinds of primary
tumors.
The fact that the primary tumor is located in a different organ establishes, by
itself, an uncontrollable difference. However, after taking into consideration
these limitations, it is not unreasonable to state that the present study offers some
interesting findings. When our patients with carcinoma of the stomach or
carcinoma of the colon were matched by sex and age, it was found that the inci-
dence of late metastases was higher in carcinoma of the colon. The distribution
of metastases in the various organs was the same for both groups of patients.
As theprimary tumor in all thesepatients had been removed, it would appear that
the factors most commonly involved in host resistance, that is sex, age or local
organ factors did not play an important role in dermining the incidence of delayed
metastases. Similar considerations, apart from the difference in sex, apply also
to the two groups of patients with carcinoma of the breast or lung. To be sure,
there may have been other host factors that are presently unknown, but the fact
that inpatients matched forage, sex andorgan involvement, there is still a differ-
ence in the incidence of late metastases suggests that a property intrinsic to the
tumor rather than the host may have been the primary factor in determining
such metastases.
Again, it must be admitted that there is a large number ofproperties intrinsic
to the tumor that can be involved as thedeterminingfactorin delaying metastases.
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However, the correlation found in tumor-pairs between the incidence of late
metastases and the interval between onset of metastases and death, does point to
the growth rate ofthe tumor as a possible important factor. In the context ofthe
present theories on late metastases, that is, the theory of the dormant cancer cell
and the growth rate theory, it is obvious that a definitive answer cannot be found
in a retrospective study on cancer patients. Furthermore, a study of this kind
cannot rule out the possibility of a dormant cancer cell, which is undoubtedly the
explanation of choice for a minority of cases of late metastases. It should be
realized, however, that most of the literature on late metastases in man is based
on case reports. This study presents for the first time a survey ofthe problem on
a relatively large scale, and the findings do show a trend which seems to be com-
patible with the growth rate theory.
SUMMARY
Out of a total of 7593 cases of malignant tumors with metastases observed at
autopsy in a 12-year period, 361 were found in which metastases were not present
at the time of the surgical removal of the primary tumor. These cases were
studied as to the time of appearance of the initial metastases. It was arbitrarily
decided to designate as late metastases those that became apparent two or more
years after removal of the primary tumor. Such tumors constituted about 10
per cent of all the cases in this series with metastases. The primary tumors that
frequently were found to give rise to late metastases were, in decreasing order of
frequency: carcinoma of the prostate and breast, sarcomas and carcinoma of the
colon and urinary bladder. The time of appearance and the frequency distribu-
tion of metastases in the various organs suggest that factors intrinsic to the tumor
play an important role in determining the incidence of late metastases.
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